MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0070783
Edenwell Therapeutics Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.02 Cr
▲ 35% YoY
Net profit · FY 2024
₹2.83 Lakh
Net margin 0.9%
EBITDA · FY 2024
₹5.81 Lakh
EBITDA margin 1.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Edenwell Therapeutics Private Limited
Data last updated:
Edenwell Therapeutics Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85320MH2017PTC296318. Its GSTIN is 27AAECE6847L1Z4 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Parvez Ahmed Abdulgaffar Kosgi and Shoeb Mohammed Kosgi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2003 W – 26 Casa Celeste – L Lodha Amara Clariant Compound Kolshet Road Thane W, Est, Maharashtra, India – 400607.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.02 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹2.83 Lakh (net margin 0.9%) and EBITDA of ₹5.81 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years and 109% over five years.
The company is associated with 1 brand: Edenwell.
Edenwell Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0070783). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website edenwelltherapeutics.com.
Company details
CIN U85320MH2017PTC296318
Registration Number 296318
Incorporation Date 19 June 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0070783
Recognitions & Rankings of Edenwell Therapeutics
Contact details
Edenwell Therapeutics Private Limited's registered office is in Thane, Maharashtra. Its website is edenwelltherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2003 W – 26 Casa Celeste – L Lodha Amara Clariant Compound Kolshet Road Thane W, Est, Maharashtra, India – 400607
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Edenwell Therapeutics Private Limited, buy the company report.
Comprehensive company report
Edenwell Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Edenwell Therapeutics operates one associated brand: Edenwell. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Clinical research and drug development services in the life sciences sector. | edenwelltherapeutics.com |
Business activity
The main business activity of Edenwell Therapeutics is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Edenwell Therapeutics Private Limited, buy the company report.
Financials of Edenwell Therapeutics Private Limited
FY 2025 filings availableEdenwell Therapeutics Private Limited reported revenue of ₹3.02 Cr (up 35% YoY) for FY 2024.
Revenue · FY 2024
₹3.02 Cr ▲ 35%
Net profit · FY 2024
₹2.83 Lakh margin 0.9%
EBITDA · FY 2024
₹5.81 Lakh margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 81%
5 years · compounded
▲ 109%
EBITDA CAGR growth
1 year
▼ 69%
3 years · compounded
▲ 2%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 109% over five years, including 35% growth in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Edenwell Therapeutics Private Limited, buy the company report.
Board of directors of Edenwell Therapeutics Private Limited
Edenwell Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvez Ahmed Abdulgaffar Kosgi Also directs: Biznexus Exim LLP, Wellshield Health LLP | Director | 19 Jun 2017 | 9 Years 4 Months | Current |
| Shoeb Mohammed Kosgi | Director | 21 Nov 2018 | 7 Years 11 Months | Current |
Auditor
Edenwell Therapeutics Private Limited is audited by J K SONEE AND ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J K SONEE AND ASSOCIATES | FY 2020 | 136562W |
Shareholding
The shareholding of Edenwell Therapeutics Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Edenwell Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Edenwell Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Edenwell Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Edenwell Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE6847L1Z4 | Maharashtra | Active | 04 Sep 2018 |
To see the full GST registrations and return filing status of Edenwell Therapeutics Private Limited, buy the company report.
Recent activity
Edenwell Therapeutics Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Kamlesh Bajirao Londhe ceased to be Director on 23 Feb 2025.
AGM
Edenwell Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Edenwell Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Kamlesh Bajirao Londhe ceased to be Director.
Ceased
Shoeb Mohammed Kosgi ceased to be Additional Director.
Appointed
Shoeb Mohammed Kosgi was appointed as Director.
Appointed
Parvez Ahmed Abdulgaffar Kosgi was appointed as Director.
Incorporation
19 Jun 2017
Edenwell Therapeutics Private Limited was registered on 19 Jun 2017 with Roc Mumbai & aged 9 years 4 months as per MCA records.
Frequently asked questions
Edenwell Therapeutics is an active private limited company based in Thane, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 19 June 2017 (9+ years old) and is registered under CIN U85320MH2017PTC296318.
Edenwell Therapeutics has 2 current directors:
- Parvez Ahmed Abdulgaffar Kosgi - Director
- Shoeb Mohammed Kosgi - Director
The latest financial statements of Edenwell Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Edenwell Therapeutics is 27AAECE6847L1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Edenwell Therapeutics is U85320MH2017PTC296318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edenwell Therapeutics was incorporated on 19 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Kamlesh Bajirao Londhe ceased to be Director on 23 Feb 2025. Shoeb Mohammed Kosgi ceased to be Additional Director on 30 Sep 2019. Shoeb Mohammed Kosgi was appointed as Director on 21 Nov 2018. Edenwell Therapeutics has 4 board changes on record in total.
Yes, Edenwell Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0070783).
Edenwell Therapeutics can be reached through the website edenwelltherapeutics.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Edenwell Therapeutics is at 2003 W – 26 Casa Celeste – L Lodha Amara Clariant Compound Kolshet Road Thane W, Est, Maharashtra, India – 400607.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages